News:
June 10, 2008
Javelin Pharmaceuticals Enrolls First Patient in Pivotal Trial
for PMI-150
June 5, 2008
Javelin Pharmaceuticals' Founder and President Transitions to Executive Director
June 4, 2008
Javelin Announces New Patent Covering PMI-150 (Intranasal Ketamine)
May 14, 2008
Javelin Pharmaceuticals Reports First Quarter 2008 Results
May 9, 2008
Javelin Pharmaceuticals to Announce First Quarter 2008 Financial Results
May 8, 2008
Javelin Pharmaceuticals, Inc. to Raise $27.6 Million through Registered Direct Offering
April 16, 2008
Javelin Pharmaceuticals Appoints John C. Taylor as Vice President of Business Development
April 1, 2008
Javelin CEO to Present at Fortis Biotechnology Conference in London England
|
Read
more 
